William Rafelson MD MBA
Genitourinary Oncology, Hematologic Oncology
Medical Director, Genitourinary Oncology
Join to View Full Profile
Atlantic Medical Group Hematology Oncology100 Madison AvenueMorristown, NJ 07960
Phone+1 973-971-7960
Fax+1 973-898-1640
Dr. Rafelson is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. William Rafelson is an oncologist in Morristown, NJ and is affiliated with Morristown Medical Center. He received his medical degree from Rutgers Robert Wood Johnson Medical School and has been in practice 4 years. He specializes in genitourinary oncology and hematologic oncology and is experienced in prostate cancer, bladder cancer, and testicular cancer.
Education & Training
Rhode Island Hospital/Brown University HealthFellowship, Hematology and Medical Oncology, 2017 - 2020- Rhode Island Hospital/Brown University HealthPost-Doctoral Fellowship, Hematology and Medical Oncology, 2016 - 2017
- Rhode Island Hospital/Brown University HealthResidency, Internal Medicine, 2013 - 2016
Rutgers Robert Wood Johnson Medical SchoolClass of 2013, MD
Certifications & Licensure
FL State Medical License 2021 - Present
NJ State Medical License 2020 - 2027
PA State Medical License 2022 - 2024
NY State Medical License 2020 - 2023
RI State Medical License 2013 - 2020
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 4 citationsA Phase 2 Trial of Talazoparib and Avelumab in Genomically Defined Metastatic Kidney Cancer.Ritesh R Kotecha, Sahil D Doshi, Andrea Knezevic, Joshua Chaim, Yingbei Chen
European Urology Oncology. 2024-08-01 - 8 citationsIdentification of incidental brain tumors in prostate cancer patients via PSMA PET/CT.Lily A McLaughlin, Onur Yildirim, Marc K Rosenblum, Brandon S Imber, Justin M Haseltine
Journal of Neuro-Oncology. 2023-06-01 - 2 citationsWhat a headache! Double-hit lymphoma with CNS recurrence - Role of chimeric antigen receptor (CAR) T-cell therapy.William Rafelson, Adam J. Olszewski
Leukemia & Lymphoma. 2020-03-20
Press Mentions
New Prostate Cancer Treatment Could Be on the Horizon, Say UK Researchers: ‘Tremendously Exciting’October 20th, 2023
Professional Memberships
- Member
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
